AMGEN 20090482- A Randomized, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid ( Zometa) In the treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma

A Randomized, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid ( Zometa) In the treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma

AMGEN 20090482
Cancer
Saad Jamshed, MD

Enrolling
Denise Maracle, RN
585.747.4555
585.922.9146